AI can be good for our health and wellbeing
07 April 2025Cambridge researchers are looking at ways that AI can transform everything from drug discovery to Alzheimer's diagnoses to GP consultations.
Antibiotics, vaccinations and anti-inflammatory medication linked to reduced risk of dementia
21 January 2025Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.
Journeys of discovery: Steve Jackson and a life-saving cancer drug
15 July 2024What excites Steve Jackson is understanding how biology works and why it sometimes goes wrong. But what galvanises him is knowing there are people alive today as a result of his discovery of how to create a cancer drug.
AI speeds up drug design for Parkinson鈥檚 ten-fold
17 April 2024Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson鈥檚 disease treatments.
Accelerating how new drugs are made with machine learning
15 January 2024Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate the design process for new drugs.
Cambridge partners with AstraZeneca and Medical Research Council on new world-class functional genomics laboratory
27 November 2023探花直播facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
AI-driven techniques reveal new targets for drug discovery
27 September 2023Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer鈥檚 disease.
Cambridge spin-out receives 拢2.2 million to help improve cancer treatments
01 March 2023has received a 拢2.2 million investment to help it take forward its drug delivery platform designed to make RNA cancer therapies more effective.
Drug-screening spin-out secures new funding
23 February 2022A 探花直播 of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a 拢2.14 million seed funding round.
Training a new breed of clinical triallist
03 February 2022Cambridge's Experimental Medicine Initiative, working with聽AstraZeneca and GSK, is training聽specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.
